GSK3-beta as a candidate therapeutic target in soft tissue sarcomas
Abstract Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown. We analyzed the prognostic impact of GSK-3β gene and protein e...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
BMC
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cbb98c95e2e745d88a7d6d2402a0a230 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|